Westfield Capital Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $154M | Buy |
|
|||||
|
2021
Q2 | $107M | Buy |
|
|||||
|
2021
Q1 | $114M | Sell |
|
|||||
|
2020
Q4 | $111M | Buy |
|
|||||
|
2020
Q3 | $95.3M | Buy |
|
|||||
|
2020
Q2 | $63.4M | Buy |
|
|||||
|
2020
Q1 | $58M | Sell |
|
|||||
|
2019
Q4 | $61M | Sell |
|
|||||
|
2019
Q3 | $48.9M | Buy |
|
|||||
|
2019
Q2 | $50.1M | Sell |
|
|||||
|
2019
Q1 | $64.1M | Buy |
|
|||||
|
2018
Q4 | $56.3M | Buy |
|
|||||
|
2018
Q3 | $67.8M | Buy |
|
|||||
|
2018
Q2 | $38.6M | Sell |
|
|||||
|
2018
Q1 | $53.7M | Sell |
|
|||||
|
2017
Q4 | $64.1M | Sell |
|
|||||
|
2017
Q3 | $57.5M | Sell |
|
|||||
|
2017
Q2 | $51.1M | Buy |
|
|||||
|
2017
Q1 | $30.4M | Sell |
|
|||||
|
2016
Q4 | $32M | Buy |
|
|||||
|
2016
Q3 | $17.4M | Sell |
|
|||||
|
2016
Q2 | $16.8M | Buy |
|